ClinicalTrials.govpublic full text
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
ovarian cancer, recurrent epithelial ovarian cancer which includes epithelial ovarian, fallopian tube and/or primary peritoneal cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 143583
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.